Published Date: August, 2017
A recent report published by Infinium Global Research on cephalosporin drugs market provides in depth analysis of segments and sub-segments in global as well as regional cephalosporin drugs market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional cephalosporin drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cephalosporin drugs market. According to report the global cephalosporin drugs market is projected to grow at a CAGR of 13.9% over the forecast period of 2017-2023.
Cephalosporins are medicine that kill bacteriaor prevent their growth. Cephalosporin drugs are a newer class of antibiotics and often are seen as an alternative to penicillin for many patients. Moreover, clinical studies are ongoing for comparing this class of antibiotics to penicillin in combating various infections. Cephalosporin drugs are used to treat infections in different parts of the body such as ears, nose, throat, lungs, sinuses, and skin. Physicians also prescribe these drugs to treat pneumonia, strep throat, staph infections, tonsillitis, bronchitis, and gonorrhea. Hence multiple benefits associated with cephalosporin drugs are likely to boost the size of global cephalosporin drugs market in the near future.
Rising prevalence of infectious diseases, increasing awareness among patients, multiple treatment options and special regulatory designation for pipeline molecules are considered to be prime factors driving the growth of cephalosporin market. Stringent government policies, low investment in R&D activities and high generic penetration of these drugs are the key restraining factors for the growth of the market. Moreover, use of combination therapies for treatment, development of highly efficient and safe cephalosporin drugs, and increasing incidence of mergers and acquisition are anticipated to bring more opportunities for the growth of this market. Furthermore, resistance by government on drug development and weak pipeline molecules are some of the primary challenges faced by the global cephalosporin drugs market.
Figure 1: Global Cephalosporin Drugs Market by Value 2015-2023
The report on global cephalosporin drugs market covers segments such as, generation of cephalosporin and route of drug administration. On the basis of generation of cephalosporin the global cephalosporin drugs market is categorized into first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin and fifth-generation cephalosporin. On the basis of route of drug administration the global cephalosporin drugs market is categorized into injection and oral.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Cephalosporin Drugs Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global cephalosporin drugs market such as, Allergan, Astellas, Bristol-Myers Squibb, GSK, Merck, Abbott, Aspen Pharmacare, AstraZeneca, Johnson & Johnson and Sun Pharmaceutical.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global cephalosporin drugs market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cephalosporin drugs market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the cephalosporin drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the cephalosporin drugs market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Cephalosporin Drugs Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Cephalosporin Drugs Market
4. Global Cephalosporin Drugs Market by Generation of Cephalosporin
4.1. First-Generation Cephalosporin
4.2. Second-Generation Cephalosporin
4.3. Third-Generation Cephalosporin
4.4. Fourth-Generation Cephalosporin
4.5. Fifth-Generation Cephalosporin
5. Global Cephalosporin Drugs Market by Route of Drug Administration
6. Global Cephalosporin Drugs Market by Region 2017-2023
6.1. North America
6.1.1. North America Cephalosporin Drugs Market by Generation of Cephalosporin
6.1.2. North America Cephalosporin Drugs Market by Route of Drug Administration
6.1.3. North America Cephalosporin Drugs Market by Country
6.2.1. Europe Cephalosporin Drugs Market by Generation of Cephalosporin
6.2.2. Europe Cephalosporin Drugs Market by Route of Drug Administration
6.2.3. Europe Cephalosporin Drugs Market by Country
6.3.1. Asia-Pacific Cephalosporin Drugs Market by Generation of Cephalosporin
6.3.2. Asia-Pacific Cephalosporin Drugs Market by Route of Drug Administration
6.3.3. Asia-Pacific Cephalosporin Drugs Market by Country
6.4.1. RoW Cephalosporin Drugs Market by Generation of Cephalosporin
6.4.2. RoW Cephalosporin Drugs Market by Route of Drug Administration
6.4.3. RoW Cephalosporin Drugs Market by Sub-region
7. Company Covered
7.3. Bristol-Myers Squibb
7.7. Aspen Pharmacare
7.9. Johnson & Johnson
7.10. Sun Pharmaceutical
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.